Article
Mutations in the reduced folate carrier gene which confer dominant resistance to 5,10-dideazatetrahydrofolate.
The Journal of biological chemistry - 2 Oct 1998
Tse A, Brigle K, Taylor S M, Moran R G
Abstract excerpt
L1210/D3 mouse leukemia cells are resistant to 5, 10-dideazatetrahydrofolate due to expansion of cellular folate pools which block polyglutamation of the drug (Tse, A., and Moran, R. G. (1998) J. Biol. Chem. 273, 25944-25952). These cells were found to have two point mutations in the reduced fola...
Topics
- Animals
- Biological Transport
- Carrier Proteins
- Cell Division
- DNA Mutational Analysis
- Drug Resistance
- Folate Receptors, GPI-Anchored
- Folic Acid
- Kinetics
- Leucovorin
- Leukemia L1210
- Methotrexate
- Mice
- Phenotype
- Point Mutation
- Pteroylpolyglutamic Acids
- RNA, Messenger
- Receptors, Cell Surface
